QIM
IONS icon

Quantitative Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quantitative Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,931
Closed -$446K – 497
2021
Q1 		$446K Sell
9,931
-8,754
-47% -$488K 0.04% 356
2020
Q4 		$1.06M Buy
+18,685
New +$931K 0.09% 239
2020
Q1 		– Sell
-46,546
Closed -$2.81M – 671
2019
Q4 		$2.81M Buy
+46,546
New +$2.77M 0.08% 248
2019
Q3 		– Sell
-138,126
Closed -$8.88M – 679
2019
Q2 		$8.88M Buy
138,126
+80,487
+140% +$5.69M 0.34% 75
2019
Q1 		$4.68M Buy
57,639
+51,739
+877% +$3.34M 0.27% 102
2018
Q4 		$318K Sell
5,900
-12,300
-68% -$627K 0.02% 442
2018
Q3 		$938K Buy
+18,200
New +$855K 0.03% 312
2017
Q3 		– Sell
-91,000
Closed -$4.63M – 760
2017
Q2 		$4.63M Buy
+91,000
New +$4.24M 0.07% 347
2016
Q3 		– Sell
-51,400
Closed -$1.2M – 760
2016
Q2 		$1.2M Buy
+51,400
New +$1.66M 0.06% 399
2016
Q1 		– Sell
-30,900
Closed -$1.91M – 836
2015
Q4 		$1.91M Sell
30,900
-34,400
-53% -$1.86M 0.12% 230
2015
Q3 		$2.64M Buy
+65,300
New +$3.38M 0.2% 132
2014
Q2 		– Sell
-9,800
Closed -$423K – 556
2014
Q1 		$423K Buy
+9,800
New +$475K 0.02% 377

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Quantitative Investment Management's IONS Position: Q2 2021 in Review

Quantitative Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 9,931 shares — an estimated $446K sold.

Quantitative Investment Management first reported a position in IONS in Q1 2014 and held it in 12 quarters. The position peaked at $8.88M in Q2 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Quantitative Investment Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 9,931 Ionis Pharmaceuticals shares in Q2 2021, an estimated $446K.
  • Quantitative Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 12 quarters.
  • Quantitative Investment Management's Ionis Pharmaceuticals position peaked at $8.88M in Q2 2019.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.